AVX-470
- Generic Name
- AVX-470
- Drug Type
- Biotech
- Background
AVX-470 is an anti-tumor necrosis factor (TNF) polyclonal antibody (bovine).
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
- First Posted Date
- 2013-01-02
- Last Posted Date
- 2014-03-05
- Lead Sponsor
- Avaxia Biologics, Incorporated
- Target Recruit Count
- 33
- Registration Number
- NCT01759056
- Locations
- 🇺🇸
Rocky Mountain Gastroenterology Associates, Lakewood, Colorado, United States
🇺🇸Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸Chevy Chase Clinical Research, Chevy Chase, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath